DCG Fentanyl Research Gains National Attention

Two researchers at The DCG have gained national attention for their groundbreaking fentanyl addiction treatment protocols. Dr. Babak Baban and Dr. Phillip Wang have discovered a new way to treat fentanyl addiction through CBD based therapy.

When studying a mouse model of fentanyl addiction, the AU team found that fentanyl use dramatically elevated neural inflammation and significantly changed innate lymphoid cells (ILCs), part of the innate immunity in the brain. With mounting evidence implicating neural inflammation and ILCs in maintaining and modulating the functions of the central nervous system (CNS), this led them to hypothesize that altered CNS immune systems may also be crucial in fentanyl induced maladaptation.

Baban and Wang have shown previously that CBD can reduce neural inflammation restore changes in ILCs, so they decided to apply a similar approach to fentanyl addiction. Through their research, they found CBD treatment significantly reversed both the elevated neural inflammation and many addiction-related behaviors.

We extend our most heartfelt appreciation to these world-class researchers for the advances they bring to important issues impacting our community and our country.

Watch the story on WJBF, picked up for wider distribution via Yahoo!News.

Watch the story on WRDW, picked up for wider distribution via MSN.

Dr. Baban and Dr. Wang previously worked together with Dr. Évila Lopes Salles on a lung cancer treatment therapy breakthrough.